obesity drug news today glp-1 september 2025 The trend: What the real-world data reveals Alarming rise in weight loss

The findings suggest that certain genetic factors may offer an explanation

If larger-scale prospective trials confirm the findings, GLP-1 agonists could potentially be explored as adjuncts to existing breast cancer prevention strategies

While more research is needed to determine the causality for ocular complications, a baseline eye examination and prompt eye care are recommended if patients experience visual changes

Wegovy (semaglutide): Specifically approved for weight management

36 Oral SNAC at 1 g/kg per day was also administered to pregnant Sprague-Dawley rats, resulting in a minor decrease in maternal body weights, prolonged gestation and an increase in stillbirths